Elliptic Laboratories AS (ELABS) — Financial Flexibility Index
Elliptic Laboratories AS (ELABS) has a Financial Flexibility Index of -0.36x as of March 2026. Free cash flow of Nkr-11.96 Million (operating CF Nkr-17.60 Million minus capex Nkr5.63 Million) represents 0% of total liabilities (Nkr33.36 Million). Check how strategically is Elliptic Laboratories AS's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Elliptic Laboratories AS Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Elliptic Laboratories AS across 9 annual periods. See ELABS working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Elliptic Laboratories AS (2017–2025)
Year-by-year free cash flow to debt coverage for Elliptic Laboratories AS. For the full company profile including market capitalisation, see ELABS market cap overview.
| Year | Flexibility Index | Free Cash Flow (NOK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.10x | Nkr35.08 Million | Nkr5.99 Million | Nkr31.87 Million | ▲ +97.4% |
| 2024 | 0.56x | Nkr19.89 Million | Nkr-10.61 Million | Nkr35.69 Million | ▲ +219.9% |
| 2023 | -0.46x | Nkr-19.90 Million | Nkr-45.51 Million | Nkr42.80 Million | ▼ -204.3% |
| 2022 | 0.45x | Nkr10.57 Million | Nkr-12.76 Million | Nkr23.70 Million | ▲ +87.8% |
| 2021 | 0.24x | Nkr6.79 Million | Nkr-10.82 Million | Nkr28.59 Million | ▼ -13.7% |
| 2020 | 0.28x | Nkr8.42 Million | Nkr-6.68 Million | Nkr30.62 Million | ▲ +435.4% |
| 2019 | 0.05x | Nkr3.05 Million | Nkr-8.05 Million | Nkr59.34 Million | ▲ +110.7% |
| 2018 | -0.48x | Nkr-26.42 Million | Nkr-35.16 Million | Nkr54.84 Million | ▲ +65.8% |
| 2017 | -1.41x | Nkr-37.50 Million | Nkr-38.87 Million | Nkr26.59 Million | — |